RxDoctor Payments DataLook up a doctor →

Adeniyi Odugbesan, MD

Endocrinology, Diabetes & Metabolism · Lawrenceville, GANPI 1528175601

Payments from drug & device makers

$1,805,283in general payments, 2019–2025

Across 3,140 payments — averaging $574.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$554K
  • Novo Nordisk AS$346K
  • Novo Nordisk$290K
  • Siemens Medical Solutions USA, Inc.$108K
  • Pfizer$71K
  • Johnson & Johnson$63K
  • plus $374K from 54 others
$2,622in research payments, 2019–2025

Across 12 payments — averaging $218.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1K
  • AbbVie$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)90$553,935
Novo Nordisk AS1,629$345,806
Novo Nordisk346$289,660
Siemens Medical Solutions USA, Inc.3$107,507
Pfizer18$70,766
Johnson & Johnson62$63,334
Merck64$58,294
Lilly USA, LLC128$53,817
AstraZeneca(2 entities)96$44,307
Amgen(2 entities)94$36,682
Bayer29$29,304
Sanofi US Services Inc.49$28,350
Boehringer Ingelheim65$26,844
Eli Lilly13$20,789
Sanofi-aventis U.S. LLC77$15,877
Abbott74$15,689
Dexcom, Inc.27$14,580
Kowa Research Institute, Inc.7$9,789
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$6,430
Amarin Pharma, Inc.21$5,630
Corcept Therapeutics42$2,933
Tandem Diabetes Care, Inc.15$740
Insulet Corporation15$666
Xeris Pharmaceuticals, Inc.16$317
BETA Bionics, Inc.6$301
BD12$265
Medtronic(2 entities)8$260
Radius Health, Inc.11$218
Madrigal Pharmaceuticals4$203
Amneal Pharmaceuticals LLC13$194
Sequel Med Tech, LLC2$183
Mannkind Corporation3$159
Ascendis Pharma Endocrinology Inc3$138
Cequr Corporation4$129
Esperion Therapeutics, Inc.3$119
Recordati_rare_diseases_inc.5$86
Embecta Corp.4$77
Vivus LLC5$72
Ascensia Diabetes Care US Inc.4$69
Kyowa Kirin, Inc.3$66
Lifescan, Inc.4$66
Amphastar Pharmaceuticals, Inc.3$59
IBSA Pharma Inc.4$57
Shire North American Group Inc4$57
Verity Pharmaceuticals Inc.3$51
Valeritas, Inc.2$37
Ionis Pharmaceuticals, Inc.2$32
Roche Diabetes Care, Inc.2$29
Acella Pharmaceuticals, LLC2$27
Amryt Pharma Holdings Ltd2$27
Senseonics, Incorporated1$23
Astellas Pharma US Inc1$18
Neurocrine Biosciences, Inc.1$18
Novartis1$18
Theracosbio, LLC2$17
Eisai Inc.1$17
Organon1$16
Nevro Corp.1$15
Bigfoot Biomedical Inc1$15
Currax Pharmaceuticals LLC1$15

How this compares

$1,805,283 in reported general payments places this provider in the 95th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.

See all endocrinology, diabetes & metabolism providers in Georgia →

Medicare billing

Part B allowed, 2024
$145,603
Medicare patients
444
Services billed
2,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Lawrenceville

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →